12.04.14
SuperSonic Imagine has received 510k clearance from the U.S. Food and Drug Administration (FDA) for two new probes used with its ultrasound machine, the Aixplorer.
The first of these newly approved devices facilitates musculoskeletal and sports medicine diagnoses. The SHL20-6 probe, a high-frequency transducer shaped like a hockey stick, provides very high resolution images of muscles, tendons, ligaments and joints. It complements the linear transducer range to provide unrivalled image quality for both very superficial and deep zones, the company said.
Jacques Souquet, founder and CEO of SuperSonic Imagine, noted that the Aixplorer’s musculoskeletal application and hockey stick probe together have “earned very positive reactions from physicians specializing in sports medicine treatment and research.” SuperSonic Imagine’s patented ShearWave Elastography system, which runs on the Aixplorer, allows practitioners to view and measure tissue stiffness of up to 800kPa in real-time. These real-time measurements are crucial for monitoring tendinopathies and examining muscular load when the muscle is in use.
While top athletes stand to benefit most from the more powerful visualization of tendons and muscles made possible by these devices, musculoskeletal disorders affect the broader population as well. They are, for instance, the primary cause of work-related illness.
The second probe cleared by the FDA is the single crystal XP5-1 transducer, which combines high sensitivity and enhanced resolution to visualize very low blood flow—an important feature for optimal transcranial doppler and abdominal vascular measurements. “Transducers like our SHL20-6 and the XP5-1 bring next-level imaging performance to the most difficult cases to image, helping physicians to make better diagnoses with minimal intervention,” Souquet said.
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine designs, develops and markets an ultrasound system called Aixplorer, which features an UltraFast platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer can image two types of waves: ultrasound waves and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner.
SuperSonic Imagine has received support from various investors, including Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.
The first of these newly approved devices facilitates musculoskeletal and sports medicine diagnoses. The SHL20-6 probe, a high-frequency transducer shaped like a hockey stick, provides very high resolution images of muscles, tendons, ligaments and joints. It complements the linear transducer range to provide unrivalled image quality for both very superficial and deep zones, the company said.
Jacques Souquet, founder and CEO of SuperSonic Imagine, noted that the Aixplorer’s musculoskeletal application and hockey stick probe together have “earned very positive reactions from physicians specializing in sports medicine treatment and research.” SuperSonic Imagine’s patented ShearWave Elastography system, which runs on the Aixplorer, allows practitioners to view and measure tissue stiffness of up to 800kPa in real-time. These real-time measurements are crucial for monitoring tendinopathies and examining muscular load when the muscle is in use.
While top athletes stand to benefit most from the more powerful visualization of tendons and muscles made possible by these devices, musculoskeletal disorders affect the broader population as well. They are, for instance, the primary cause of work-related illness.
The second probe cleared by the FDA is the single crystal XP5-1 transducer, which combines high sensitivity and enhanced resolution to visualize very low blood flow—an important feature for optimal transcranial doppler and abdominal vascular measurements. “Transducers like our SHL20-6 and the XP5-1 bring next-level imaging performance to the most difficult cases to image, helping physicians to make better diagnoses with minimal intervention,” Souquet said.
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine designs, develops and markets an ultrasound system called Aixplorer, which features an UltraFast platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer can image two types of waves: ultrasound waves and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner.
SuperSonic Imagine has received support from various investors, including Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.